Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Page 1
Pulmonary embolism in COVID-19 pneumonia patients admitted to temporary hospital - The follow-up study.
Lewczuk T, Kazimierczyk R, Sobkowicz B, Lisowska A. Lewczuk T, et al. Among authors: sobkowicz b. Adv Med Sci. 2023 Sep;68(2):270-275. doi: 10.1016/j.advms.2023.08.002. Epub 2023 Aug 24. Adv Med Sci. 2023. PMID: 37633116
It seems that simple D-dimer concentration assessment at admission may be a helpful tool not only to predict PE but also to estimate the long-term prognosis....
It seems that simple D-dimer concentration assessment at admission may be a helpful tool not only to predict PE but also to estimate the lon …
The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET/MRI hybrid imaging-follow-up study.
Kazimierczyk R, Szumowski P, Nekolla SG, Malek LA, Blaszczak P, Hladunski M, Sobkowicz B, Mysliwiec J, Kaminski KA. Kazimierczyk R, et al. Among authors: sobkowicz b. EJNMMI Res. 2023 Mar 9;13(1):20. doi: 10.1186/s13550-023-00971-w. EJNMMI Res. 2023. PMID: 36892707 Free PMC article.
Clinical Trial Registration ClinicalTrials.gov, NCT03688698, 05/01/2016, https://clinicaltrials.gov/ct2/show/study/NCT03688698?term=NCT03688698&draw=2&rank=1....
Clinical Trial Registration ClinicalTrials.gov, NCT03688698, 05/01/2016, https://clinicaltrials.gov/ct2/show/study/NCT03688698?term=N …
Comparing Atrial-Fibrillation Validated Rapid Scoring Systems in the Long-Term Mortality Prediction in Patients Referred for Elective Coronary Angiography: A Subanalysis of the Bialystok Coronary Project.
Rogalska E, Kurasz A, Kuźma Ł, Bachórzewska-Gajewska H, Dobrzycki S, Koziński M, Sobkowicz B, Tomaszuk-Kazberuk A. Rogalska E, et al. Among authors: sobkowicz b. Int J Environ Res Public Health. 2022 Aug 21;19(16):10419. doi: 10.3390/ijerph191610419. Int J Environ Res Public Health. 2022. PMID: 36012052 Free PMC article.
Our aim was to assess the utility of CHA2DS2-VASc, HASBLED, and 2MACE scores in predicting long-term mortality in the population of the Bialystok Coronary Project, including AF patients. ...However, in our study, the CHA2DS2-VASc and 2MACE scores outperformed the HASBLED s …
Our aim was to assess the utility of CHA2DS2-VASc, HASBLED, and 2MACE scores in predicting long-term mortality in the population of t …
A 39-Year-Old Woman with Ventricular Electrical Storm Treated with Emergency Cardiac Defibrillation Followed by Multidisciplinary Management.
Sielatycki P, Chlabicz M, Sawicki R, Hirnle T, Sobkowicz B, Kamiński KA, Dobrzycki S. Sielatycki P, et al. Among authors: sobkowicz b. Am J Case Rep. 2022 Jun 14;23:e935710. doi: 10.12659/AJCR.935710. Am J Case Rep. 2022. PMID: 35698443 Free PMC article.
Multidisciplinary clinical follow-up is required to investigate and treat any reversible causes and to ensure long-term stabilization of cardiac rhythm....
Multidisciplinary clinical follow-up is required to investigate and treat any reversible causes and to ensure long-term stabilization …
Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project.
Kuźma Ł, Tomaszuk-Kazberuk A, Kurasz A, Dobrzycki S, Koziński M, Sobkowicz B, Lip GYH. Kuźma Ł, et al. Among authors: sobkowicz b. J Clin Med. 2021 Oct 26;10(21):4949. doi: 10.3390/jcm10214949. J Clin Med. 2021. PMID: 34768472 Free PMC article.
Over the next decades, the prevalence of atrial fibrillation (AF) is estimated to double. Our aim was to investigate the causes of the long-term mortality in relation to the diagnosis of atrial fibrillation (AF) and chronic coronary syndrome (CCS). ...The main findings are …
Over the next decades, the prevalence of atrial fibrillation (AF) is estimated to double. Our aim was to investigate the causes of the long- …
Clinical application of stress echocardiography in valvular heart disease: an expert consensus of the Working Group on Valvular Heart Disease of the Polish Cardiac Society.
Płońska-Gościniak E, Kukulski T, Hryniewiecki T, Kasprzak JD, Kosmala W, Olszowska M, Mizia-Stec K, Pysz P, Zaborska B, Stokłosa P, Gąsior Z; Reviewers (on behalf of the Working Group on Valvular Heart Disease); Reviewers (on behalf of the Polish Cardiac Society). Płońska-Gościniak E, et al. Kardiol Pol. 2020 Jun 25;78(6):632-641. doi: 10.33963/KP.15360. Epub 2020 May 18. Kardiol Pol. 2020. PMID: 32419441 Free article.
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z, Yip WLJ, Zhang S, Khan A, Deng CQ, Grover R, Tapson VF; FREEDOM-EV Investigators. White RJ, et al. Am J Respir Crit Care Med. 2020 Mar 15;201(6):707-717. doi: 10.1164/rccm.201908-1640OC. Am J Respir Crit Care Med. 2020. PMID: 31765604 Free PMC article. Clinical Trial.
The primary endpoint was the time to first adjudicated clinical worsening event: death; hospitalization due to worsening PAH; initiation of inhaled or parenteral prostacyclin therapy; disease progression; or unsatisfactory long-term clinical response.Measurements and Main …
The primary endpoint was the time to first adjudicated clinical worsening event: death; hospitalization due to worsening PAH; initiation of …
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV. Barco S, et al. Among authors: sobkowicz b. Clin Res Cardiol. 2019 Jul;108(7):772-778. doi: 10.1007/s00392-018-1405-1. Epub 2018 Dec 18. Clin Res Cardiol. 2019. PMID: 30564950 Free PMC article. Clinical Trial.
METHODS: In a post hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial, we focused on 219 survivors of acute intermediate-risk PE with clinical and echocardiographic follow-up 6 months after randomisation as well as over the long term (median, 3 years after …
METHODS: In a post hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial, we focused on 219 survivors of acute intermediate-ris …
Different manifestations of pulmonary embolism in younger compared to older patients: Clinical presentation, prediction rules and long-term outcomes.
Kiluk IE, Krajewska A, Kosacka U, Tycińska A, Milewski R, Musiał W, Sobkowicz B. Kiluk IE, et al. Among authors: sobkowicz b. Adv Med Sci. 2017 Sep;62(2):254-258. doi: 10.1016/j.advms.2017.01.001. Epub 2017 May 11. Adv Med Sci. 2017. PMID: 28501724
We found no differences in clinical signs, symptoms, and treatment between the two groups. In-hospital (2% vs. 13%) and long-term (12% vs. 36%) mortality rates were significantly lower in younger patients (P=0.003). ...
We found no differences in clinical signs, symptoms, and treatment between the two groups. In-hospital (2% vs. 13%) and long-term (12 …
19 results